Literature DB >> 18031690

How do adjuvants work? Important considerations for new generation adjuvants.

Amy S McKee1, Michael W Munks, Philippa Marrack.   

Abstract

In this Commentary, McKee et al. highlight the properties of extrinsic vaccine adjuvants that must be considered to achieve the most protective immune response, as occurs naturally with many intrinsic pathogen-derived adjuvants.

Mesh：

Substances：

Year:  2007        PMID： 18031690     DOI： 10.1016/j.immuni.2007.11.003

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


  83 in total

Review 1.  Vaccination: the present and the future.

Authors:  Saheli Sadanand
Journal:  Yale J Biol Med       Date:  2011-12

Review 2.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

3.  Notch controls the magnitude of T helper cell responses by promoting cellular longevity.

Authors:  Christina Helbig; Rebecca Gentek; Ronald A Backer; Yevan de Souza; Ingrid A M Derks; Eric Eldering; Koen Wagner; Dragana Jankovic; Thomas Gridley; Perry D Moerland; Richard A Flavell; Derk Amsen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

Review 4.  Key roles of adjuvants in modern vaccines.

Authors:  Steven G Reed; Mark T Orr; Christopher B Fox
Journal:  Nat Med       Date:  2013-12-05       Impact factor: 53.440

5.  A self-assembling peptide acting as an immune adjuvant.

Authors:  Jai S Rudra; Ye F Tian; Jangwook P Jung; Joel H Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

6.  Development of effective cancer vaccine using targeting system of antigen protein to APCs.

Authors:  Tomoaki Kurosaki; Takashi Kitahara; Tadahiro Nakamura; Koyo Nishida; Shintaro Fumoto; Yukinobu Kodama; Hiroo Nakagawa; Norihide Higuchi; Hitoshi Sasaki
Journal:  Pharm Res       Date:  2011-09-02       Impact factor: 4.200

7.  Nucleotide oligomerization domain-containing proteins instruct T cell helper type 2 immunity through stromal activation.

Authors:  Joao G Magalhaes; Stephen J Rubino; Leonardo H Travassos; Lionel Le Bourhis; Wei Duan; Gernot Sellge; Kaoru Geddes; Karou Geddes; Colin Reardon; Matthias Lechmann; Leticia A Carneiro; Thirumahal Selvanantham; Jorg H Fritz; Betsy C Taylor; David Artis; Tak Wah Mak; Michael R Comeau; Michael Croft; Stephen E Girardin; Dana J Philpott
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-19       Impact factor: 11.205

Review 8.  Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant.

Authors:  C R Casella; T C Mitchell
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

9.  Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3.

Authors:  Hanfen Li; Stephen B Willingham; Jenny P-Y Ting; Fabio Re
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 10.  Recent advances in the development of vaccines for tuberculosis.

Authors:  Mohamed Jawed Ahsan
Journal:  Ther Adv Vaccines       Date:  2015-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.